Considering the crucial role of glucose supply for sustaining accelerated tumor metabolism and most malignant cells’ overexpression of GLUT1 and GLUT3, strategies are being devised to effectively inhibit GLUTs in a neoplastic cell-specific manner. The gene discussed is SLC2A1; the disease is neoplasm.